Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics


Autoria(s): WARDMAN, Jonathan H.; ZHANG, Xin; GAGNON, Sandra; CASTRO, Leandro M.; ZHU, Xiaorong; STEINER, Donald F.; DAY, Robert; FRICKER, Lloyd D.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2010

Resumo

P>Neuropeptides are produced from larger precursors by limited proteolysis, first by endopeptidases and then by carboxypeptidases. Major endopeptidases required for these cleavages include prohormone convertase (PC) 1/3 and PC2. In this study, quantitative peptidomics analysis was used to characterize the specific role PC1/3 plays in this process. Peptides isolated from hypothalamus, amygdala, and striatum of PC1/3 null mice were compared with those from heterozygous and wild-type mice. Extracts were labeled with stable isotopic tags and fractionated by HPLC, after which relative peptide levels were determined using tandem mass spectrometry. In total, 92 peptides were found, of which 35 were known neuropeptides or related peptides derived from 15 distinct secretory pathway proteins: 7B2, chromogranin A and B, cocaine- and amphetamine-regulated transcript, procholecystokinin, proenkephalin, promelanin concentrating hormone, proneurotensin, propituitary adenylate cyclase-activating peptide, proSAAS, prosomatosatin, provasoactive intestinal peptide, provasopressin, secretogranin III, and VGF. Among the peptides derived from these proteins, similar to 1/3 were decreased in the PC1/3 null mice relative to wild-type mice, similar to 1/3 showed no change, and similar to 1/3 increased in PC1/3 null. Cleavage sites were analyzed in peptides that showed no change or that decreased in PC1/3 mice, and these results were compared with peptides that showed no change or decreased in previous peptidomic studies with PC2 null mice. Analysis of these sites showed that while PC1/3 and PC2 have overlapping substrate preferences, there are particular cleavage site residues that distinguish peptides preferred by each PC.

National Institutes of Health (NIH)[DA-04494]

U.S. National Institutes of Health (NIH)

National Institutes of Health (NIH)[DK-13914]

U.S. National Institutes of Health (NIH)

Howard Hughes Medical Institute

Howard Hughes Medical Institute

Canadian Institutes of Health Research

Canadian Institutes of Health Research (CIHR)

FRSQ

FRSQ

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[04/04933-2]

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[04/14846-0]

Financiadora de Estudos e Projetos (FINEP)[A-03/134]

Financiadora de Estudos e Projetos (FINEP)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Identificador

JOURNAL OF NEUROCHEMISTRY, v.114, n.1, p.215-225, 2010

0022-3042

http://producao.usp.br/handle/BDPI/28076

10.1111/j.1471-4159.2010.06760.x

http://dx.doi.org/10.1111/j.1471-4159.2010.06760.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL

Relação

Journal of Neurochemistry

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL

Palavras-Chave #neuropeptide #peptidase #peptide processing #proprotein convertase #proSAAS #protease #STABLE ISOTOPIC TAGS #PROPROTEIN CONVERTASES #MASS-SPECTROMETRY #BASIC RESIDUES #CATHEPSIN-L #MAJOR ROLE #MICE #PC2 #CLEAVAGE #CELLS #Biochemistry & Molecular Biology #Neurosciences
Tipo

article

original article

publishedVersion